Alzheimer’s disease affects more than 6 million people in the United States, and there are very few FDA-approved treatments that can slow the progression of the disease.
As Medicare spending on remote patient monitoring jumps, HHS watchdog warns of fraud, misuse
The federal watchdog at the Department of Health and Human Services issued a report on Tuesday calling for more oversight of remote patient monitoring in
September 24, 2024